Robustness trade-offs and host-microbial symbiosis in the immune system

Molecular Systems Biology

Volumn 2, Issue , 2006, Pages

  Kitano, Hiroaki ^a,b,c   Oda, Kanae ^a,c  

^a Systems Biology Institute   (Japan)

^b SONY COMPUTER SCIENCE LABORATORIES INC   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Autoimmune diseases; Bacteria flora; Immunology; Micro organisms; Robustness

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; BACTERIAL FLORA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMBIOSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

BACTERIA; IMMUNE SYSTEM; SYMBIOSIS;

BACTERIA (MICROORGANISMS);

EID: 33745470929     PISSN: 17444292     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb4100039     Document Type: Review

References (85)

1. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-793
2. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150
3. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680
4. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347: 911-920
5. Bach JF (2005) The protective effect of infections on immune disorders. J Pediatr Gastroenterol Nutr 40 (Suppl 1): S8
6. Backhed F, Ley R, Sonnenburg J, Peterson D, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307: 1915-1920
7. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113
8. Baum H, Davies H, Peakman M (1996) Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 17: 64-70
9. Bergogne-Berezin E (2000) Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 16: 521-526
10. Beutler B (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263
11. Bracke JW, Cruden DL, Markovetz AJ (1979) Intestinal microbial flora of the of the American cockroach, Periplaneta americana L. Appl Environ Microbiol 38: 945-955
12. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33-39
13. Carlson JM, Doyle J (2000) Highly optimized tolerance: robustness and design in complex systems. Phys Rev Lett 84: 2529-2532
14. Carlson JM, Doyle J (2002) Complexity and robustness. Proc Natl Acad Sci USA 99 (Suppl 1): 2538-2545
15. Csete M, Doyle J (2004) Bow ties, metabolism and disease. Trends Biotechnol 22: 446-450
16. Day R (2002) Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis. Lancet 359: 540-541
17. Delong EF (2005) Microbial community genomics in the ocean. Nat Rev Microbiol 3: 459-469
18. Dunne JA, Williams RJ, Martinez ND (2002) Food-web structure and network theory: the role of connectance and size. Proc Natl Acad Sci USA 99: 12917-12922
19. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9: 1484-1490
20. Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN (2004) Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease? Novartis Found Symp 256: 53-69; discussion 69-73, 106-111, 266-109
21. Feldmann M, Maini RN (2002) Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies. Joint Bone Spine 69: 12-18
22. Gilroy DW, Lawrence T, Perretti M, Rossi AG (2004) Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3: 401-416
23. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209
24. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309
25. Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, Virzi E, Rescigno M, Moro G, Ricciardi-Castagnoli P (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2: 882-888
26. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30: 61-67
27. Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22: 283-307
28. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881-884
29. Horak I, Lohler J, Ma A, Smith KA (1995) Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev 148: 35-44
30. Hornef MW, Wick MJ, Rhen M, Normark S (2002) Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 3: 1033-1040
31. Jordan MS, Singer AL, Koretzky GA (2003) Adaptors as central mediators of signal transduction in immune cells. Nat Immunol 4: 110-116
32. Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3: 984-993
33. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122
34. Kitano H (2004) Biological robustness. Nat Rev Genet 5: 826-837
35. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734
36. Li L, Alderson D, Tanaka R, Doyle J, Willinger W (2004a) Towards a Theory of Scale-free Graphs: Definition, Properties, and Implications (Extended Version). Pasadena, CA: California Institute of Technology
37. Li L, Alderson D, Willinger W, Doyle J (2004b) A first-principle approach to understand the Internet's Router-level topology. Proceedings of ACM Sigcomm. Portland, OR: ACM
38. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734
39. Liew FY (2002) T(H)1 and T(H)2 cells: a historical perspective. Nat Rev Immunol 2: 55-60
40. Luther SA, Cyster JG (2001) Chemokines as regulators of T cell differentiation. Nat Immunol 2: 102-107
41. Ma HW, Zeng AP (2003) The connectivity structure, giant strong component and centrality of metabolic networks. Bioinformatics 19: 1423-1430
42. Macpherson AJ, Hunziker L, McCoy K, Lamarre A (2001) IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect 3: 1021-1035
43. Macpherson AJ, Martinic MM, Harris N (2002) The functions of mucosal T cells in containing the indigenous commensal flora of the intestine. Cell Mol Life Sci 59: 2088-2096
44. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591
45. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, Eckmann L, Karin M (2005) Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1 beta processing. Science 307: 734-738
46. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H (2002) Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 80: 477-483
47. Mai V, Morris Jr JG (2004) Colonic bacterial flora: changing understandings in the molecular age. J Nutr 134: 459-464
48. Malek TR, Bayer AL (2004) Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4: 665-674
49. McCune JM (2001) The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410: 974-979
50. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145
51. Mills KH (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855
52. Moser M, Murphy KM (2000) Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1: 199-205
53. Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2: 933-944
54. Nathan C (2002) Points of control in inflammation. Nature 420: 846-852
55. Nicholson JK, Holmes E, Wilson ID (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 3: 431-438
56. Nicholson JK, Wilson ID (2003) Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2: 668-676
57. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, Timmis KN, Schreiber S (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53: 685-693
58. Oxley AP, Shipton W, Owens L, McKay D (2002) Bacterial flora from the gut of the wild and cultured banana prawn, Penaeus merguiensis. J Appl Microbiol 93: 214-223
59. Read S, Powrie F (2001) CD4(+) regulatory T cells. Curr Opin Immunol 13: 644-649
60. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK (2001) Type 1T regulatory cells. Immunol Rev 182: 68-79
61. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway Jr CA (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353: 622-627
62. Sartor RB (2003) Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastroenterol 19: 358-365
63. Sartor RB (2005) Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 21: 44-50
64. Savage DC (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31: 107-133
65. Schmitt-Wagner D, Friedrich MW, Wagner B, Brune A (2003) Phylogenetic diversity, abundance, and axial distribution of bacteria in the intestinal tract of two soil-feeding termites (Cubitermes spp.). Appl Environ Microbiol 69: 6007-6017
66. Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2: 389-400
67. Stappenbeck TS, Hooper LV, Gordon JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 99: 15451-15455
68. Stelling J, Sauer U, Szallasi Z, Doyle III FJ, Doyle J (2004) Robustness of cellular functions. Cell 118: 675-685
69. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65: 4799-4807
70. Sullivan A, Nord CE (2005) Probiotics and gastrointestinal diseases. J Intern Med 257: 78-92
71. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M, Lochs H (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54
72. Tanaka R (2005) Scale-rich metabolic networks. Phys Rev Lett 94: 168101
73. Tiveljung A, Soderholm JD, Olaison G, Jonasson J, Monstein HJ (1999) Presence of eubacteria in biopsies from Crohn's disease inflammatory lesions as determined by 16S rRNA gene-based PCR. J Med Microbiol 48: 263-268
74. Ushijima T, Ozaki Y (1986) Potent antagonism of Escherichia coli, Bacteroides ovatus, Fusobacterium varium, and Enterococcus faecalis, alone or in combination, for enteropathogens in anaerobic continuous flow cultures. J Med Microbiol 22: 157-163
75. Ushijima T, Ozaki Y (1988) Factors influencing potent antagonistic effects of Escherichia coli and Bacteroides ovatus on Staphylococcus aureus in anaerobic continuous flow cultures. Can J Microbiol 34: 645-650
76. Venter JC, Remington K, Heidelberg JF, Halpern AL, Rusch D, Eisen JA, Wu D, Paulsen I, Nelson KE, Nelson W, Fonts DE, Levy S, Knap AH, Lomas MW, Nealson K, White O, Peterson J, Hoffman J, Parsons R, Baden-Tillson H, Pfannkoch C, Rogers YH, Smith HO (2004) Environmental genome shotgun sequencing of the Sargasso Sea. Science 304: 66-74
77. von Boehmer H (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6: 338-344
78. von Herrath MG, Fujinami RS, Whitton JL (2003) Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 1: 151-157
79. Weiner HL (2001) The mucosal milieu creates tolerogenic dendritic cells and T (R)1 and T(H)3 regulatory cells. Nat Immunol 2: 671-672
80. Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, Hooper LV, Gordon JI (2003) A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299: 2074-2076
81. Xu J, Gordon JI (2003) Inaugural article: honor thy symbionts. Proc Natl Acad Sci USA 100: 10452-10459
82. Yachi S, Loreau M (1999) Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis. Proc Natl Acad Sci USA 96: 1463-1468
83. Yewdell JW, Bennink JR (2001) Cut and trim: generating MHC class I peptide ligands. Curr Opin Immunol 13: 13-18
84. Zoetendal EG, Akkermanns AD, Akkermanns-van Vliet WM, Arjan G, de Visser GM, de Vos WM (2001) The host genotype affects the bacterial community in the human gastrointestinal trace. Microb Ecol Health Dis 13: 129-134
85. Zuany-Amorim C, Hastewell J, Walker C (2002) Toll-like receptors as potential therapeutic targets for multiple diseases. Nat Rev Drug Discov 1: 797-807